Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 32 filings·Updated 17 Aug 2026
Showing 10 of 32 filings.
17 Aug 20261 filing
Corp. ActionBook Closure

Bodal Chemicals books closure for 40th AGM; e-voting window and cut-off dates set

Book closure and AGM details

  • Book closure from 19 September 2026 to 25 September 2026, both days inclusive.
  • Purpose: book closure for the 40th AGM.
  • Record/cut-off: e-voting eligibility cut-off on 18 September 2026.
  • E-voting period: 22 September 2026, 9:00 a.m. to 24 September 2026, 5:00 p.m.
  • AGM date: 25 September 2026 at 12:00 p.m.
  • Security: equity shares.
  • E-voting via CDSL eVoting platform.
Filed 14:52View Source
7 Aug 20261 filing
Company UpdateNewspaper Publication

Bodal Chemicals Limited herewith inform exchange about news paper copies for result publication

Filed 12:34View Source
5 Aug 20262 filings
Company UpdateInvestor Presentation

Bodal Chemicals Q1 FY27 revenue Rs 7.15B, EBITDA Rs 0.75B, PAT Rs 0.30B; YoY growth driven by integrated model

Business Overview

  • Integrated chemical manufacturer with eight facilities across Gujarat, Punjab, and UP.
  • Saykha benzene downstream products started contributing to topline in Q1 FY27.
  • Strategy prioritizes value-added products and backward integration for margin protection.
  • Exports account for about 25% of revenue; key clients include LANXESS, SRF, ACETO, IRNET.

Key Operational Highlights

  • Q1 FY27 revenue Rs 7,152 million, up 56% YoY.
  • EBITDA Rs 751 million; EBITDA margin 10.5%.
  • PAT consolidated Rs 303.8 million; PAT margin 4.2%.
  • Dye Intermediates revenue up 44% YoY; Dyestuffs up 23%.
  • Chlor Alkali revenue Rs 870 million; up 3% YoY.
  • Sener Boya (Turkey) revenue up 41%; PAT Rs 22 million.
  • China and Indonesia subsidiaries remained subdued; Saykha and domestic units grew.

Financial Performance

  • Consolidated revenue Rs 7,151.9 million; up 56.1% YoY.
  • Total consolidated EBITDA Rs 751.0 million; margin 10.5%.
  • Profit after tax Rs 303.8 million; PAT margin 4.2%.
  • Standalone revenue Rs 7,035.7 million; PAT Rs 287.8 million.
  • Finance cost Rs 185.7 million; interest expense impacting profitability.
  • EPS consolidated Rs 2.4; standalone Rs 2.3.

Capital Structure & Liquidity

  • No new debt or equity actions disclosed in the presentation.
  • Finance costs indicate ongoing financing needs; no explicit liquidity actions disclosed.

Strategic Priorities & Outlook

  • Focus on value-added products and Saykha benzene downstream contribution.
  • Maintain margins via integrated model and RM cost pass-through.
  • Exports about 25% of revenue; leverage global client relationships.
  • Past expansions and pollution-control investments to support growth.

Risks & Mitigation

  • RM cost volatility due to crude-linked inputs; mitigated by pass-through.
  • Energy and water scarcity pose production risks; ETP and MEEP deployment.
  • Regulatory costs rising; Bluesign and ISO certifications indicate compliance.

Governance & Leadership

  • Chairman and MD Suresh J. Patel leads with independent directors on board.
  • CFO Mayank Mehta oversees finance and investor relations.
  • Overseas subsidiaries include Sener Boya (Turkey), Bodal China, Bodal Indonesia.
Filed 18:42View Source
ResultFinancial Results

Bodal Chemicals reports standalone and consolidated Q1 FY27 unaudited results; standalone revenue Rs 6.98bn, PAT Rs 287.8m; consolidated revenue Rs 7.09bn, PAT Rs 303.8m.

Standalone results

  • Standalone revenue from operations: Rs 6,982.96m for quarter ended 30 Jun 2026.
  • Standalone total income: Rs 7,035.75m, up about 21.5% QoQ.
  • Standalone total expenses: Rs 6,648.34m.
  • Standalone PBT: Rs 387.41m; tax Rs 99.58m; PAT Rs 287.83m.
  • Standalone basic and diluted EPS: Rs 2.29.
  • SGST incentive recognised in revenue: Rs 25.71m.
  • Ind AS 108 Chemical segment is the only reportable segment.

Consolidated results

  • Consolidated revenue from operations: Rs 7,090.41m; total income: Rs 7,151.88m.
  • Consolidated total expenses: Rs 6,760.68m; PBT Rs 391.20m.
  • Consolidated tax expense: Rs 87.41m; PAT Rs 303.79m.
  • Consolidated EPS: Basic Rs 2.41; Diluted Rs 2.41.
  • Hyperinflation restatement: net impact Rs 13.10m charged; Rs 15.29m opened retained earnings.
  • Consolidated segment: Chemicals; four subsidiaries not reviewed; group deemed non-material.
Filed 18:31View Source
27 Jul 20261 filing
Board Meeting

Bodal Chemicals to hold board meeting on 5 August 2026 to consider unaudited Q1 results and AGM dates

Meeting Details

  • Board meeting on 5 August 2026 at Bodal Corporate House, Ahmedabad, or via video conferencing.

Key Agenda Items

  • Consider and approve unaudited standalone and consolidated financial results for quarter ended 30 June 2026.
  • Decide date of 40th AGM and book closure dates for year ended 31 March 2026.
  • Any other business with permission of the Chairman.

Other Notes

  • Trading window closed; will reopen 48 hours after results declaration on 8 August 2026.
Filed 17:13View Source
6 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Dematerialisation processing completed; securities listed and depository owner updated under Reg 74(5).

Dematerialisation status

  • Dematerialisation requests were processed; confirmations issued to depositories (accepted/rejected).
  • Securities dematerialised have been listed on the stock exchanges where they are listed.
  • Physical certificates received for dematerialisation were mutilated and cancelled after verification.
  • Depository's name substituted as registered owner in the records within prescribed timelines.
Filed 11:06View Source
29 Jun 20261 filing
Insider Trading / SASTClosure of Trading Window

Bodal Chemicals Trading Window Closure Notice

Trading Window

  • Trading window closes from 01 July 2026.
  • Reopens 48 hours after declaration of the quarter ended 30 June 2026 results.
Filed 11:23View Source
11 May 20261 filing
Company UpdateReg.24(A)-Annual Secretarial Compliance

Bodal Chemicals Limited herewith submit Annual Secretarial Compliance Report for year ended 31 March 2026

Filed 13:03View Source
24 Apr 20261 filing
OthersFormat of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....

Filed 14:46View Source
14 Apr 20261 filing
Company UpdateNewspaper Publication

Bodal Chemicals Limited herewith submit News Paper Publication

Filed 16:44View Source
Showing 10 of 32 filings